CHEK1 and medulloblastoma: Moreover, our data show that the inhibition of ERβ leads to enhanced ATR/Chk1 phosphorylation and the expected transition from G2/M to G1 cell cycle arrest [22], which was associated with better survival of medulloblastoma cells in the presence of cisplatin (Figs. 1 and 2).